HepatolInt(2009)3:480–489DOI10.1007/s12072-009-9132-3
ORIGINALARTICLE
Arandomizedcontrolledtrialofthymalfasinplustransarterialchemoembolizationforunresectablehepatocellularcarcinoma
RobertG.GishÆStuartC.GordonÆ
DavidNelsonÆVinodRustgiÆIsraelRios
Received:30June2008/Accepted:20April2009/Publishedonline:8May2009ÓAsianPaci cAssociationfortheStudyoftheLiver2009
Abstract
PurposePatientswithadvancedhepatocellularcarci-noma(HCC)havefewtreatmentoptions.Thymalfasin(thymosina-1)isanimmunomodulatorthatmayincreaseresponsetoablativetherapythroughdirectanti-tumoractionorenhancedprotectionagainstinfections.Wecomparedtransarterialchemoembolization(TACE)plusthymalfasinwithTACEaloneforunresectableHCC.
MethodsInthisphaseII,randomizedtrial,25patientsreceivedeitherTACEplusthymalfasin(1.6mgSC,5timesweekly;n=14)orTACEalone(n=11)for24weeks.Responsewasde nedastransitiontotransplant
R.G.Gish(&)
DepartmentofHepatologyandComplexGastroenterology,CaliforniaPaci cMedicalCenter,2340ClaySt.#233,SanFrancisco,CA94115,USAe-mail:GishR@sutterhealth.org
S.C.Gordon
DivisionofHepatology,HenryFordHealthSystem,2799WestGrandBoulevard,Detroit,MI48202-2689,USAe-mail:sgordon3@hfhs.org
D.Nelson
SectionofHepatologyandLiverTransplantation,UniversityofFloridaCollegeofMedicine,Gainesville,FL32610-0214,USAe-mail:david.nelson@medicine.u .edu
V.Rustgi
MetropolitanLiverandGastroenterologyCenter,8316ArlingtonBoulevard,Suite515,Fairfax,VA22301,USAe-mail:HepGi@aol.com
I.Rios
SciClonePharmaceuticals,Inc.,950TowerLane,Suite900,FosterCity,CA94404-1573,USAe-mail:irios@sciclone.com
eligibilityorlackofdiseaseprogressionthroughweek72.Survivalwasassessedthrough24monthspost-treatment.ResultsEightoffourteen(57.1%)patientsintheTACE?thymalfasingroupversus5of11(45.5%)patientsintheTACE-onlygroupbecameresponders(P=1.0).FouroffourteenTACE?thymalfasinpatientsversusnoneof11TACE-onlypatientsbecameeligiblefortransplant.Medianoverallsurvivaltimewas110.3weeksfortheTACE?thymalfasingroupversus57.0weeksfortheTACE-onlygroup(P=0.45).Sevenpatientsineachgroupexperiencedseriousadverseevents;therewerenobacterialinfectionsintheTACE?thymalfasingroupversus4intheTACE-onlygroup.Therewere3deathsintheTACE?thymalfasingroupand5intheTACE-onlygroup.
ConclusionsInpatientswithunresectableHCC,TACE?thymalfasinresultedinnumericallyhigherratesofsurvivalandtumorresponse,includingtransplantcan-didacy,withfewerbacterialinfections,thanTACEalone.TreatmentregimensforHCCincludingthymalfasinasanimmunomodulatorshouldbeevaluatedinlargertrials.KeywordsHepatocellularcarcinomaÁUnresectableÁThymosina-1ÁTransarterialchemoembolizationÁTACE
Introduction
Hepatocellularcarcinoma(HCC)isthe fthmostcommonsolidtumorintheworld,andthethirdmostcommoncauseofcancerdeath[1,2].Between500,000and1millionnewcasesofHCCarediagnosedannually[2,3].EvidencedocumentsthattheincidenceofHCCisrisingacrossseveralcountries,includingtheUnitedStates[4–6].The
123
A开头英语单词_英语学习_外语学习_教育专区。首页
a an和the用法和练习_英语学习_外语学习_教育专区。初中英语该会的a an the的用法以及相应的练习。a an the an, a 是不定冠词,仅用在单数可数名词前面,...
各种标准纸张大小A1,A2,A3,A4纸的尺寸_专业资料。有需要查看各种纸张尺寸的朋友,请下载此文档。最标准的各种纸张尺寸,比如A0\A1\A2\A3\A4的各种尺寸都有...
A0-A4纸张尺寸_专业资料。A0=1189*841 A1=841*594 A2=594*420 A3=420*297 A4规格:210*297 单位是毫米 纸张的规格是指纸张制成后,经过修整切边,裁成...
告诉你什么叫A++屏幕 不懂别装_计算机软件及应用_IT/计算机_专业资料。告诉你什么叫 A++屏幕 不懂别装液晶面板按照品质可以分为 A、B、C 三个等级,其等级...
A1、A2、A3、A4的纸尺寸分别是多少?_机械/仪表_工程科技_专业资料 暂无评价0人阅读0次下载举报文档 A1、A2、A3、A4的纸尺寸分别是多少?_机械/仪表_...
A0,A1,A2,A3,A4图纸标准大小和格式_人文社科_专业资料 暂无评价0人阅读0次下载举报文档 A0,A1,A2,A3,A4图纸标准大小和格式_人文社科_专业资料。...
A1、A2、A3、A4的纸尺寸分别是多少_建筑/土木_工程科技_专业资料 暂无评价0人阅读0次下载举报文档 A1、A2、A3、A4的纸尺寸分别是多少_建筑/土木_工程...
2014年 练习册上册 语文七年级A人教版 答案_初一语文_语文_初中教育_教育专区。2014年 练习册上册 语文七年级A人教版 答案今日推荐 ...
2014语文练习册七年级上A版答案_语文_初中教育_教育专区 暂无评价0人阅读0次下载举报文档 2014语文练习册七年级上A版答案_语文_初中教育_教育专区。 ...
热门文档